Procept Total Assets from 2010 to 2025

PRCT Stock

USD 58.10 0.23 0.40%

Procept Biorobotics Total Assets yearly trend continues to be comparatively stable with very little volatility. Total Assets will likely drop to about 325.1 M in 2025. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2010-12-31

Previous Quarter

534 M

Current Value

325.1 M

Quarterly Volatility

158.6 M

Credit Downgrade

Yuan Drop

Covid

Check Procept Biorobotics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Procept Biorobotics' main balance sheet or income statement drivers, such as Net Interest Income of 7 M, Interest Income of 11.4 M or Depreciation And Amortization of 4 M, as well as many indicators such as Price To Sales Ratio of 17.76, Dividend Yield of 0.0 or PTB Ratio of 10.96. Procept financial statements analysis is a perfect complement when working with Procept Biorobotics Valuation or Volatility modules.

Check out the analysis of Procept Biorobotics Correlation against competitors.

Latest Procept Biorobotics' Total Assets Growth Pattern

Below is the plot of the Total Assets of Procept Biorobotics Corp over the last few years. Total assets refers to the total amount of Procept Biorobotics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Procept Biorobotics Corp books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Procept Biorobotics' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Procept Biorobotics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 534.02 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Procept Total Assets Regression Statistics

	Arithmetic Mean	166,004,232
	Geometric Mean	113,641,452
	Coefficient Of Variation	95.54
	Mean Deviation	135,015,694
	Median	61,995,000
	Standard Deviation	158,595,385
	Sample Variance	25152.5T
	Range	472M
	R-Value	0.81
	Mean Square Error	9315.5T
	R-Squared	0.65
	Significance	0.0001
	Slope	26,946,011
	Total Sum of Squares	377287.4T

Procept Total Assets History

	2025	325.1 M
	2024	534 M
	2023	404.7 M
	2022	309.3 M
	2021	337 M
	2020	126 M

Other Fundumenentals of Procept Biorobotics Corp

Intangibles To Total Assets

Procept Biorobotics Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Short Term Debt	Intangible Assets	Property Plant Equipment	Short Long Term Debt	Capital Surpluse	Deferred Long Term Liab	Common Stock
Total Assets		0.95	0.94	0.85	-0.95	-0.94	0.86	0.92	0.82	-0.74	0.96	1.0	1.0	-0.2	-0.98	0.86	-0.53	-0.53	-0.53	0.69
Total Stockholder Equity	0.95		0.98	0.9	-0.98	-0.95	0.81	0.88	0.86	-0.84	1.0	0.95	0.95	-0.29	-0.95	0.87	-0.68	-0.68	-0.68	0.68
Net Tangible Assets	0.94	0.98		0.79	-0.97	-0.88	0.79	0.89	0.74	-0.9	0.98	0.94	0.95	-0.26	-0.91	0.8	-0.54	-0.54	-0.54	0.54
Current Deferred Revenue	0.85	0.9	0.79		-0.83	-0.97	0.8	0.74	1.0	-0.57	0.89	0.84	0.83	-0.35	-0.91	0.93	-0.86	-0.86	-0.86	0.85
Net Debt	-0.95	-0.98	-0.97	-0.83		0.9	-0.72	-0.91	-0.8	0.81	-0.98	-0.96	-0.97	0.14	0.92	-0.79	0.63	0.63	0.63	-0.65
Retained Earnings	-0.94	-0.95	-0.88	-0.97	0.9		-0.89	-0.87	-0.95	0.65	-0.95	-0.93	-0.92	0.27	0.98	-0.96	0.73	0.73	0.73	-0.77
Accounts Payable	0.86	0.81	0.79	0.8	-0.72	-0.89		0.78	0.76	-0.63	0.82	0.84	0.81	-0.35	-0.91	0.91	-0.4	-0.4	-0.4	0.5
Long Term Debt	0.92	0.88	0.89	0.74	-0.91	-0.87	0.78		0.69	-0.62	0.89	0.92	0.92	0.1	-0.92	0.82	-0.47	-0.47	-0.47	0.5
Net Receivables	0.82	0.86	0.74	1.0	-0.8	-0.95	0.76	0.69		-0.52	0.86	0.81	0.79	-0.34	-0.88	0.91	-0.87	-0.87	-0.87	0.87
Total Liab	-0.74	-0.84	-0.9	-0.57	0.81	0.65	-0.63	-0.62	-0.52		-0.83	-0.75	-0.76	0.49	0.68	-0.56	0.35	0.35	0.35	-0.35
Net Invested Capital	0.96	1.0	0.98	0.89	-0.98	-0.95	0.82	0.89	0.86	-0.83		0.96	0.96	-0.27	-0.95	0.88	-0.68	-0.68	-0.68	0.67
Total Current Assets	1.0	0.95	0.94	0.84	-0.96	-0.93	0.84	0.92	0.81	-0.75	0.96		1.0	-0.19	-0.97	0.84	-0.53	-0.53	-0.53	0.69
Net Working Capital	1.0	0.95	0.95	0.83	-0.97	-0.92	0.81	0.92	0.79	-0.76	0.96	1.0		-0.18	-0.96	0.82	-0.53	-0.53	-0.53	0.68
Short Term Debt	-0.2	-0.29	-0.26	-0.35	0.14	0.27	-0.35	0.1	-0.34	0.49	-0.27	-0.19	-0.18		0.22	-0.34	0.28	0.28	0.28	-0.39
Intangible Assets	-0.98	-0.95	-0.91	-0.91	0.92	0.98	-0.91	-0.92	-0.88	0.68	-0.95	-0.97	-0.96	0.22		-0.94	0.62	0.62	0.62	-0.71
Property Plant Equipment	0.86	0.87	0.8	0.93	-0.79	-0.96	0.91	0.82	0.91	-0.56	0.88	0.84	0.82	-0.34	-0.94		-0.71	-0.71	-0.71	0.7
Short Long Term Debt	-0.53	-0.68	-0.54	-0.86	0.63	0.73	-0.4	-0.47	-0.87	0.35	-0.68	-0.53	-0.53	0.28	0.62	-0.71		1.0	1.0	-0.8
Capital Surpluse	-0.53	-0.68	-0.54	-0.86	0.63	0.73	-0.4	-0.47	-0.87	0.35	-0.68	-0.53	-0.53	0.28	0.62	-0.71	1.0		1.0	-0.8
Deferred Long Term Liab	-0.53	-0.68	-0.54	-0.86	0.63	0.73	-0.4	-0.47	-0.87	0.35	-0.68	-0.53	-0.53	0.28	0.62	-0.71	1.0	1.0		-0.8
Common Stock	0.69	0.68	0.54	0.85	-0.65	-0.77	0.5	0.5	0.87	-0.35	0.67	0.69	0.68	-0.39	-0.71	0.7	-0.8	-0.8	-0.8

Click cells to compare fundamentals

About Procept Biorobotics Financial Statements

Procept Biorobotics shareholders use historical fundamental indicators, such as Total Assets, to determine how well the company is positioned to perform in the future. Although Procept Biorobotics investors may analyze each financial statement separately, they are all interrelated. The changes in Procept Biorobotics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Procept Biorobotics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

		Last Reported	Projected for Next Year
	Total Assets	534 M	325.1 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Procept Stock Analysis

When running Procept Biorobotics' price analysis, check to measure Procept Biorobotics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procept Biorobotics is operating at the current time. Most of Procept Biorobotics' value examination focuses on studying past and present price action to predict the probability of Procept Biorobotics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procept Biorobotics' price. Additionally, you may evaluate how the addition of Procept Biorobotics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC